Cost‐related medication nonadherence among Medicare beneficiaries with cardiovascular disease risk factors: The role of comprehension of the Medicare programme and its prescription drug benefits.

Rationale, Aims, and Objectives: This study aims to investigate how reported comprehension of the Medicare programme and its prescription drug benefits is associated with cost‐related medication nonadherence (CRN) among Medicare beneficiaries with cardiovascular disease (CVD) risk factors. Methods: This cross‐sectional study used the 2017 Medicare Current Beneficiary Survey Public Use File data and included Medicare beneficiaries aged ≥65 years who reported having at least one CVD risk factor (i.e., hypertension, hyperlipidemia, diabetes, smoking and obesity) (n = 2821). A survey‐weighted logistic model was used to examine associations between perceived difficulty of understanding the Medicare programme and its prescription drug benefits and CRN, controlling for beneficiaries' demographic (e.g., age) and clinical characteristics (e.g, comorbidities). This study further analyzed five subgroups based on the type of CVD risk factors involved. Results: Among Medicare beneficiaries with CVD risk factors, 14.4% reported CRN. Medicare beneficiaries with CVD risk factors who reported difficulty understanding the overall Medicare programme and its prescription drug benefits were more likely to report CRN, compared to those who reported easy understanding of the overall Medicare programme (OR = 1.50; 95% CI = 1.11−2.04; p = 0.009) and its prescription drug benefits (OR = 2.01; 95% CI = 1.52−2.66; p < 0.001). Similar results were obtained for the subgroups with obesity, hypertension or hyperlipidemia. Conclusions: Perceived difficulty of understanding the Medicare Programme and its prescription drug benefits is associated with CRN among Medicare beneficiaries with CVD risk factors, especially those with obesity, hypertension or hyperlipidemia. Monitoring and enhancing Medicare beneficiaries' overall understanding of the Medicare programme may reduce CRN. [ABSTRACT FROM AUTHOR]